Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923). (Q33348042)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923). |
scientific article |
Statements
Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923) (English)
R E N van Rijswijk
J B Vermorken
N Reed
G Favalli
C Mendiola
F Zanaboni
J P Guastalla
W W ten Bokkel Huinink
A J Lacave
H Bonnefoi
S Tumulo
R Rietbroek
I Teodorovic
C Coens